MOKARI ATABAK (Chief Financial Officer) received a stock award from CORCEPT THERAPEUTICS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 3/4/2026ACC: 0001193125-26-092155
Officer· Chief Financial Officer
Since Mar 2021
+698.00
Net shares
Net buyer
$3.5K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
794.00 acquired · 96.00 disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+397.00
Price / share
$35.97
Trade value
$14.28K
% of position
2.7%
3/2/2026
14.56K→14.96K
Common Stock
Direct
Shares
+397.00
Price / share
—
Trade value
—
% of position
2.7%
3/2/2026
14.96K→15.35K
Common Stock
Direct
Shares
−96.00
Price / share
$35.97
Trade value
$3.45K
% of position
0.6%
3/3/2026
15.35K→15.26K
Total
Net shares
+698.00
Net value
$10.83K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | A · Award | +397.00 | $35.97 | $14.28K | 2.7% | 14.56K | 14.96K |
| Common Stock Direct | 3/2/2026 | A · Award | +397.00 | — | — | 2.7% | 14.96K | 15.35K |
| Common Stock Direct | 3/3/2026 | F · Tax Withholding | −96.00 | $35.97 | $3.45K | 0.6% | 15.35K | 15.26K |
| Total | +698.00 | $10.83K | ||||||
Derivative Transactions0
No derivative transactions reported